![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2019
Müller, Rüdiger B.; Späth, Michael; Restorff, Cord von; Ackermann, Christoph; Schulze-Koops, Hendrik und Kempis, Johannes von
(2019):
Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol.
In: Journal of Clinical Medicine, Bd. 8, Nr. 3, 302
2017
Müller, Rüdiger B.; Reshiti, Nazim; Kägi, Toni; Finckh, Axel; Haile, Sarah R.; Schulze-Koops, Hendrik; Schiff, Michael; Späth, Michael und Kempis, Johannes von
(2017):
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
In: Clinical Rheumatology, Bd. 36, Nr. 1: S. 59-66